{"transactions":[{"id":4616232,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40594,"kind":"person","name":"Hoffman John Francis","position":1,"cik":"0002070006","reported_name":"Hoffman John Francis","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:22.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":121968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":4.5,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":121968},"source":{"system":"sec-edgar","filing":"0001140361-26-036383","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036383/form4.xml","form_type":"4"}},{"id":4616231,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40594,"kind":"person","name":"Hoffman John Francis","position":1,"cik":"0002070006","reported_name":"Hoffman John Francis","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:22.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":206000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of July 15, 2026, by and among AtaiBeckley Inc. (the \"Company\"), Eli Lilly and Company, an Indiana corporation (\"Parent\"), and Albali Acquisition Corporation, a Delaware corporation and indirect wholly owned subsidiary of Parent (\"Merger Sub\"), on September 11, 2026, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":2.25,"expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":206000},"source":{"system":"sec-edgar","filing":"0001140361-26-036383","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036383/form4.xml","form_type":"4"}},{"id":746596,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40594,"kind":"person","name":"Hoffman John Francis","position":1,"cik":"0002070006","reported_name":"Hoffman John Francis","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-09T00:00:35.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":121968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before AtaiBeckley Inc.'s next annual meeting or June 4, 2027, subject to continued service on AtaiBeckley Inc.'s board of directors through the applicable vesting date."}],"balance_after":121968,"derivative":{"exercise_price":4.5,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":121968},"source":{"system":"sec-edgar","filing":"0001140361-26-024523","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126024523/form4.xml","form_type":"4"}},{"id":1100519,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40594,"kind":"person","name":"Hoffman John Francis","position":1,"cik":"0002070006","reported_name":"Hoffman John Francis","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-27T21:31:24.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":206000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest as to 1/3rd of the underlying shares on June 26, 2026 and as to the remaining underlying shares in twenty-four (24) substantially equal monthly installments thereafter, such that the option will become fully vested on June 26, 2028."}],"balance_after":206000,"derivative":{"exercise_price":2.25,"expiration_date":"2035-06-26","underlying":"Common Shares","underlying_shares":206000},"source":{"system":"sec-edgar","filing":"0001140361-25-024020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2070006/000114036125024020/form4.xml","form_type":"4"}}]}